New Jersey A 5051: Codifies certain regulatory provisions regarding controlled dangerous substances and prescription monitoring.

Status: Introduced in the Assembly, Referred to Assembly Health and Senior Services Committee (as of 2019-02-14)

State: New Jersey · Session: 218 · Bill: A 5051

Subjects: DRUG ABUSE, PHARMACEUTIC

Sponsors: Murphy, Carol A., Vainieri Huttle, Valerie

View New Jersey A 5051 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.